CompletedInterventionalNot ApplicableUpdated Jun 29, 2025
The Application of Target Controlled Infusion of Etomidate Combined With Propofol in the Maintenance of Anesthesia During Brain Surgeries | NCT02174120 | Trialant
Unknown statusInterventionalPhase 4Updated Jun 25, 2014
The Application of Target Controlled Infusion of Etomidate Combined With Propofol in the Maintenance of Anesthesia During Brain Surgeries
ClinicalTrials.gov ID
NCT02174120
Lead Sponsor
Henan Provincial People's HospitalOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
120Estimated
Last Update Posted
Jun 25, 2014Estimated
Start Date
Oct 2014
Primary Completion Date
Sep 2015Estimated
Completion Date
Sep 2015Estimated
Brief Summary
To explore the application of target controlled infusion of etomidate combined with propofol in the maintenance of anesthesia during brain surgeries.
Target Controlled Infusion
General Anesthesia
propofol
etomidate
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged between 60 and 80 years Brain surgeries Body weight is between 45 to 75 kg and body mass index is no more than 30 kg/m2 American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ Expected operation duration is between 3 and 5 h Signed informed consent form
Exclusion Criteria:
Serious cardiac, cerebral(acute stroke, uncontrolled seizure, sever dementia), liver, kidney, lung, endocrine disease or sepsis History of general anesthesia within 24 h before the operation Long use of hormone or history of adrenal suppression Hyperlipidaemia Long use of psychotropic substances Systolic pressure is still under 90 mm Hg after twice given of vasopressor agent Suspected abuse of narcotic analgesia Patients need to use neuromuscular blocking drugs (except intubation) Allergy to trial drug or other contraindication Pregnant or breast-feeding women Attendance of other trial past 30 days